DBC1 re-expression alters the expression of multiple components of the plasminogen pathway

Oncogene

Volumn 25, Issue 16, 2006, Pages 2409-2419

  Louhelainen, J P ^a   Hurst, C D ^a   Pitt, E ^a   Nishiyama, H ^a   Pickett, H A ^a   Knowles, M A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; DBC1; Expression microarray; Tumour suppressor gene

Indexed keywords

COMPLEMENTARY DNA; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METALLOTHIONEIN I; PLASMINOGEN; PROTEIN; RNA; SMALL PROLINE RICH PROTEIN 2B; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL AGING; CHROMOSOME 9Q; DBC1 GENE; DNA MICROARRAY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECEPTORS, RETINOIC ACID; SERPINS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 33646141861     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209228     Document Type: Article

References (37)

1. Bachmann F. (1995). Thromb Haemost 74: 172-179.
2. Barradas M, Gonos ES, Zebedee Z, Kolettas E, Petropoulou C, Delgado MD et al. (2002). Exp Cell Res 273: 127-137.
3. Champelovier P, Boucard N, Levacher G, Simon A, Seigneurin D, Praloran V. (2002). Urol Res 30: 301-309.
4. Cohen RL, Niclas J, Lee WM, Wun TC, Crowley CW, Levinson AD et al. (1989). J Biol Chem 264: 8375-8383.
5. Eller MS, Yaar M, Ostrom K, Harkness DD, Gilchrest BA. (1995). J Cell Sci 108(Part 8): 2741-2746.
6. Foucre D, Bouchet C, Hacene K, Pourreau-Schneider N, Gentile A, Martin PM et al. (1991). Br J Cancer 64: 926-932.
7. Fujiwara H, Emi M, Nagai H, Ohgaki K, Imoto I, Akimoto M et al. (2001). J Hum Genet 46: 372-377.
8. Fujiyama C, Jones A, Fuggle S, Bicknell R, Cranston D, Harris AL. (2001). Br J Cancer 84: 558-564.
9. Habuchi T, Luscombe M, Elder PA, Knowles MA. (1998). Genomics 48: 277-288.
10. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S et al. (2001). Oncogene 20: 531-537.
11. Habuchi T, Yoshida O, Knowles MA. (1997). Hum Mol Genet 6: 913-919.
12. Hamada T, Sasaguri T, Tanimoto A, Arima N, Shimajiri S, Abe T et al. (1996). Biochem Biophys Res Commun 219: 829-834.
13. Hasui Y, Osada Y. (1997). J Natl Cancer Inst 89: 678-679.
14. Hudson MA, McReynolds LM. (1997). J Natl Cancer Inst 89: 709-717.
15. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. (2004). Oncogene 23: 2250-2263.
16. Hurst RE, Waliszewski P, Waliszewska M, Bonner RB, Benbrook DM, Dar A et al. (1999). Adv Exp Med Biol 462: 449-467.
17. Ioachim EE, Charchanti AV, Stavropoulos NE, Athanassiou ED, Michael MC, Agnantis NJ. (2001). Anticancer Res 21: 1757-1761.
18. Jensen PH, Cressey LI, Gjertsen BT, Madsen P, Mellgren G, Hokland P et al. (1994). Br J Cancer 70: 834-840.
19. Kawano H, Nakatani T, Mori T, Ueno S, Fukaya M, Abe A et al. (2004). Mol Brain Res 125: 60-75.
20. Knowles MA. (1999). Electrophoresis 20: 269-279.
21. Kondo Y, Kuo SM, Lazo JS. (1994). J Pharmacol Exp Ther 270: 1313-1318.
22. Marvin KW, George MD, Fujimoto W, Saunders NA, Bernacki SH, Jetten AM. (1992). Proc Natl Acad Sci USA 89: 11026-11030.
23. Mouton RE, Venable ME. (2000). Mech Ageing Dev 113: 169-181.
24. Nishiyama H, Gill JH, Pitt E, Kennedy W, Knowles MA. (2001). Oncogene 20: 2956-2964.
25. Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. (1999). Genes Chromosomes Cancer 26: 171-175.
26. Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH et al. (2000). Environ Health Perspect 108: 413-418.
27. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T et al (2004). Oncogene 23: 5095-5098.
28. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. (1999). Curr Biol 9: 939-945.
29. Simpkins CO. (2000). Cell Mol Biol 46: 465-488.
30. Stadler WM, Steinberg G, Yang X, Hagos F, Turner C, Olopade OI. (2001). Clin Cancer Res 7: 1676-1682.
31. Toshiyuki N, Ichiro M. (2004). Mol Brain Res 125: 47-59.
32. Tsangaris GT, Tzortzatou-Stathopoulou F. (1998). Anticancer Res 18: 2423-2433.
33. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. (2002). Genome Biol 3, research0034.1-0034.11.
34. Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J et al. (2002). Genes Chromosomes Cancer 34: 86-96.
35. Wright KO, Messing EM, Reeder JE. (2002). J Urol 168: 2645-2649.
36. Wright KO, Messing EM, Reeder JE. (2004). Oncogene 23: 82-90.
37. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD. (2003). Cell Res 13: 319-333.